Titan Pharmaceuticals Inc SC 13G and SC 13G/A reports

Location
400 Oyster Point Blvd, Suite 505, San Francisco, CA
State of incorporation
Delaware
Fiscal year end
December 31
Data updated at
8/22/2024, 01:24 AM
Form type Sec Links Description Filing date Reporting date
SC 13G/A Report SC 13G/A Feb 14, 2022
SC 13G/A Report TITAN PHARMACEUTICALS, INC. Jan 24, 2022
SC 13G/A Report SABBY 13G-A TTNP 1.03.22 Jan 3, 2022
SC 13G Report SC 13G Jan 25, 2021
SC 13G Report SABBY 13G TTNP 1.22.21 Jan 22, 2021
SC 13G Report TITAN PHARMACEUTICALS, INC. Jan 21, 2021
SC 13G/A Report SABBY 13G-A TTNP 1.07.21 Jan 7, 2021
SC 13G Report SCHEDULE 13G Nov 9, 2020
SC 13G Report SC 13G Oct 1, 2020
SC 13G Report SABBY 13G TTNP 9.24.20 Sep 24, 2020
SC 13G/A Report TITAN PHARMACEUTICALS, INC. Jan 27, 2020
SC 13G/A Report SABBY 13G-A TTNP 1.13.20 Jan 13, 2020
SC 13G Report TITAN PHARMACEUTICALS, INC. Oct 22, 2019
SC 13G Report SABBY 13G TTNP 8.07.19 Aug 7, 2019
SC 13G/A Report SC 13G/A Feb 8, 2018
SC 13G/A Report SC 13G/A Apr 19, 2017
SC 13G/A Report Feb 10, 2017
SC 13G/A Report Feb 12, 2016
SC 13G/A Report AMENDMENT Feb 3, 2016
SC 13G/A Report AMENDMENT Feb 6, 2015
SC 13G Report Oct 10, 2014
SC 13G Report SC 13G May 21, 2014
SC 13G/A Report Feb 14, 2014
SC 13G/A Report Jun 7, 2013
SC 13G/A Report Feb 14, 2013
SC 13G/A Report Feb 11, 2013
SC 13G/A Report Feb 14, 2012
SC 13G Report Feb 7, 2012
SC 13G/A Report Feb 11, 2011
SC 13G Report Feb 5, 2010